Prime Medicine (PRME) Net Margin (2024 - 2026)

Prime Medicine (PRME) reported Net Margin of 5738.55% for Q1 2026, down 216978.0% on a YoY basis from N/an in Q1 2025, and down 4.36% quarter-over-quarter from 5498.69% in Q4 2025.

Prime Medicine (PRME) Net Margin (2024 - 2026) Analysis & Trends

Prime Medicine has reported Net Margin for 3 years, with the latest figure at 5738.55% in Q1 2026.

  • For the quarter ending Q1 2026, Net Margin fell 216978.0% year-over-year to 5738.55%; the trailing twelve-month figure through Mar 2026 stood at 4917.55% (up 33495.0% YoY), and the FY2025 full-year result was 4342.44%, up 222417.0% from the prior year.
  • Net Margin for Q1 2026 stood at 5738.55%, down from 5498.69% in the prior quarter.
  • The five-year high for Net Margin was 1936.6% in Q4 2024, with the low at 25128.23% in Q3 2024.
  • Historically, Net Margin has averaged 7307.46% across 3 years, with a median of 5107.68% in 2025.
  • The largest YoY upside for Net Margin was 2099909 bps in 2025 against a maximum downside of 356209 bps in 2025.
  • Prime Medicine's Net Margin stood at 1936.6% in 2024, then sank by 184 bps to 5498.69% in 2025, then dropped by 4 bps to 5738.55% in 2026.
  • The last three Net Margin figures came in at 5738.55% (Q1 2026), 5498.69% (Q4 2025), and 4129.14% (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.82%
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 34.53%
9 Abivax 91.96 Bn 91.96 Bn - -
10 Prime Medicine 572.02 Mn 572.02 Mn - -5,738.55%

Historic Data

Download Data
DateValue
Mar 31, 2026 -5,738.55%
Dec 31, 2025 -5,498.69%
Sep 30, 2025 -4,129.14%
Jun 30, 2025 -4,716.68%
Mar 31, 2025 -3,568.78%
Dec 31, 2024 -1,936.60%
Sep 30, 2024 -25,128.23%
Mar 31, 2024 -7,742.98%